DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 168 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,678,000 | +60.3% | 882,814 | -27.5% | 0.12% | +84.8% |
| Q4 2020 | $5,415,000 | -50.8% | 1,216,844 | -52.3% | 0.07% | -67.3% |
| Q3 2020 | $11,010,000 | -75.5% | 2,548,620 | -49.7% | 0.20% | -75.6% |
| Q2 2020 | $44,901,000 | +640.2% | 5,062,100 | +396.5% | 0.83% | +110.4% |
| Q1 2017 | $6,066,000 | +46.3% | 1,019,491 | -2.9% | 0.39% | +10.4% |
| Q4 2016 | $4,147,000 | -76.7% | 1,049,791 | +44.9% | 0.36% | -73.5% |
| Q3 2015 | $17,775,000 | – | 724,348 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |